Journal of Neuroimmunology
Volume 178, Issue 1 , Pages 1-8 , September 2006

IL-10 is essential for disease protection following intranasal peptide administration in the C57BL/6 model of EAE

  • Emma J. O’Neill

      Affiliations

    • School of Agriculture, Food Science and Veterinary Medicine, College of Life Sciences, Belfield, Dublin 4, Ireland
    • Corresponding Author InformationCorresponding author. Tel.: +353 1716 6025; fax: +353 1716 6023.
    • ,
  • Michael J. Day

      Affiliations

    • Division of Veterinary Pathology, Infection and Immunity, Department of Clinical Veterinary Science, University of Bristol, Langford House, Langford, BS40 5DU, UK
    • ,
  • David C. Wraith

      Affiliations

    • Department of Cellular and Molecular Medicine, University of Bristol, Medical School, University Walk, Bristol BS8 1TD, UK

Received 24 February 2006 ,Revised 23 May 2006 ,Accepted 26 May 2006.

References 

  1. Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K. Role of interleukin 10 in specific immunotherapy. J. Clin. Invest. 1998;102:98–106
  2. Akkaraju S, Ho WY, Leong D, Canaan K, Davis MM, Goodnow CC. A range of CD4 T cell tolerance: partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis. Immunity. 1997;7:255–271
  3. Anderton SM, Wraith DC. Hierarchy in the ability of T cell epitopes to induce peripheral tolerance to antigens from myelin. Eur. J. Immunol. 1998;28:1251–1261
  4. Baker D, O'Neill JK, Gschmeissner SE, Wilcox CE, Butter C, Turk JL. Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice. J. Neuroimmunol. 1990;28:261–267
  5. Bettelli E, Das MP, Howard ED, Weiner HL, Sobel RA, Kuchroo VK. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 1998;161:3299–3306
  6. Burkhart C, Liu GY, Anderton SM, Metzler B, Wraith DC. Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for interleukin-10. Int. Immunol. 1999;11:1625–1634
  7. Cottrez F, Hurst SD, Coffman RLHG. T regulatory cells 1 inhibit a Th2-specific response in vivo. J. Immunol. 2000;165:4848–4853
  8. Daniel D, Wegmann DR. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9–23). Proc. Natl. Acad. Sci. U. S. A. 1996;93:956–960
  9. Duda PW, Schmied MC, Cook SL, Krieger JI, Hafler DA. Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis. J. Clin. Invest. 2000;105:967–976
  10. Eng LF, Ghirnikar RS, Lee YL. Inflammation in EAE: role of chemokine/cytokine expression by resident and infiltrating cells. Neurochem. Res. 1996;21:511–525
  11. Goodin DS, Frohman EM, Garmany GP, Halper J, Likosky WH, Lublin FD, et al. Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines. Neurology. 2002;58:169–178
  12. Groux H, Bigler M, de Vries JE, Roncarolo M-G. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J. Exp. Med. 1996;184:19–29
  13. Kommajosyula S, Reddy S, Nitschke K, Kanwar JR, Karanam M, Krissansen GW. Leukocytes infiltrating the pancreatic islets of nonobese diabetic mice are transformed into inactive exiles by combinational anti-cell adhesion therapy. J. Leukoc. Biol. 2001;70:510–517
  14. Larche M, Wraith DC. Peptide-based therapeutic vaccines for allergic and autoimmune diseases. Nat. Med. 2005;11:S69–S76
  15. Levings MK, Sangregorio R, Galbiati F, Squadrone S, de Waal Malefyt R, Roncarolo MG. IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol. 2001;166:5530–5539
  16. Maron R, Melican NS, Weiner HL. Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes. J. Autoimmun. 1999;12:251–258
  17. Mathisen PM, Yu M, Johnson JM, Drazba JA, Tuohy VK. Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells. J. Exp. Med. 1997;186:159–164
  18. Metzler B, Wraith DC. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int. Immunol. 1993;5:1159–1165
  19. Oldfield WL, Larche M, Kay AB. Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial. Lancet. 2002;360:47–53
  20. Prakken BJ, Samodal R, Le TD, Giannoni F, Yung GP, Scavulli J, et al. Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis. Proc. Natl. Acad. Sci. U. S. A. 2004;101:4228–4233
  21. Racke MK, Quigley L, Cannella B, Raine CS, McFarlin DE, Scott DE. Superantigen modulation of experimental allergic encephalomyelitis: activation of energy determines outcome. J. Immunol. 1994;152:2051–2059
  22. Shen CR, Youssef AR, Devine A, Bowie L, Hall AM, Wraith DC, et al. Peptides containing a dominant T-cell epitope from red cell band 3 have in vivo immunomodulatory properties in NZB mice with autoimmune hemolytic anemia. Blood. 2003;102:3800–3806
  23. Sundstedt A, O'Neill EJ, Nicolson KS, Wraith DC. Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo. J. Immunol. 2003;170:1240–1248
  24. Tian J, Atkinson MA, Clare-Salzer M, Herschenfeld A, Forsthuber T, Lehmann PV, et al. Nasal administration of glutamate decarboxylase (GAD 65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J. Exp. Med. 1996;183:1561–1567
  25. Wraith DC. Role of interleukin-10 in the induction and function of natural and antigen-induced regulatory T cells. J. Autoimmun. 2003;20:273–275
  26. Wraith DC. Vaccines for the treatment of autoimmune diseases. In:  Levine Myron M,  Rino Rappuoli JBK,  Liu Margaret,  Good Michael editor. New Generation Vaccines. New York: Marcel Dekker Inc.; 2004;p. 1047–1056
  27. Xu LY, Huang YM, Yang JS, Van der Meide PH, Link H, Xiao BG. Suppression of ongoing experimental allergic encephalomyelitis (EAE) in Lewis rats: synergistic effects of myelin basic protein (MBP) peptide 68–86 and IL-4. Clin. Exp. Immunol. 2000;120:526–531
  28. Zhang J, Hutton G, Zang Y. A comparison of the mechanisms of action of interferon beta and glatiramer acetate in the treatment of multiple sclerosis. Clin. Ther. 2002;24:1998–2021

PII: S0165-5728(06)00210-4

doi: 10.1016/j.jneuroim.2006.05.030

Journal of Neuroimmunology
Volume 178, Issue 1 , Pages 1-8 , September 2006

Article Tools

* Image Usage & Resolution